![Luke Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 805 536 $ in data 31/05/2026
Dr. Luke N.
Walker, MD, is a Chief Medical Officer at Umoja Biopharma, Inc., an Independent Director at Context Therapeutics, Inc. and an Independent Director at Zentalis Pharmaceuticals, Inc. He is on the Board of Directors at Context Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. Dr. Walker was previously employed as a Chief Medical Officer by Harpoon Therapeutics, Inc., a Vice President-Clinical Development by Seagen, Inc., and a Vice President-Clinical Development by CASCADIAN THERAPEUTICS INC.
He received his doctorate degree from the University of Oklahoma College of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/06/2026 | 201.384 ( 0,28% ) | 805 536 $ | 31/05/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 29/05/2024 |
| CONTEXT THERAPEUTICS INC. | Direttore/Membro del Consiglio | 04/09/2024 |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Direttore Tecnico/Scientifico/R&S | 01/01/2025 |
| Società | Posizione | Fine |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01/10/2022 |
| CASCADIAN THERAPEUTICS INC (USA) | Direttore Tecnico/Scientifico/R&S | 09/03/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Oklahoma College of Medicine
 University of Oklahoma College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
